down arrow

Ishita Drugs

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
82.20
-0.5 (-0.6%)
BSENSE

Apr 11, 12:30 PM

BSE+NSE Vol: 170

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 25.81% vs -14.32% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 19.26% vs -30.19% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 67.60% vs 117.81% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 29.63% vs -28.27% in Mar 2023

Compare Profit and Loss Results of Ishita Drugs
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
15.00
9,264.00
-9,249.00
-99.84%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
15.00
9,264.00
-9,249.00
-99.84%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-25.00
25.00
100.00%
Raw Materials Consumed
11.00
2,933.00
-2,922.00
-99.62%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
1.00
1,982.00
-1,981.00
-99.95%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
14.00
6,939.00
-6,925.00
-99.80%
Operating Profit (PBDIT) excl Other Income
0.00
2,325.00
-2,325.00
-100.00%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
1.00
2,592.00
-2,591.00
-99.96%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
1.00
2,577.00
-2,576.00
-99.96%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
2,259.00
-2,259.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
2,259.00
-2,259.00
-100.00%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
0.00
1,823.00
-1,823.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
6.00
7,868.00
-7,862.00
-99.92%
Profit Available for appropriations
6.00
9,691.00
-9,685.00
-99.94%
Appropriations
6.00
9,691.00
-9,685.00
-99.94%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.5
45.52
-43.02
-94.51%
Profit And Loss - Net Sales
Net Sales 15.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 25.81% vs -14.32% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.91 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.26% vs -30.19% in Mar 2023

Profit And Loss - Interest
Interest 0.09 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 67.60% vs 117.81% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 0.75 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 29.63% vs -28.27% in Mar 2023